SP-MHCI-0347-3

Influenza A (strain A/Duck/Hong Kong/2986.1/2000 H5N1 genotype C) Neuraminidase 233-241, CVNGSCFTV

US$507.00

In stock

Description

About Influenza A (strain A/Duck/Hong Kong/2986.1/2000 H5N1 genotype C) Neuraminidase 233-241, CVNGSCFTV

The Influenza A (strain A/Duck/Hong Kong/2986.1/2000 H5N1 genotype C) Neuraminidase Peptide (IEDB: 7291) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Neuraminidase Peptide, H-CVNGSCFTV-OH (Uniprot: Q8QPK2 aa: 233-241) from JPT is produced under strict quality control and quality management.

Influenza A (strain A/Duck/Hong Kong/2986.1/2000 H5N1 genotype C) Neuraminidase 233-241, CVNGSCFTV - Specifications

  • Peptide sequence: H-CVNGSCFTV-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Hepatitis, Influenza
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Influenza A (strain A/Duck/Hong Kong/2986.1/2000 H5N1 genotype C) Neuraminidase 233-241, CVNGSCFTV

References:
Read References with JPT’s Antigen Peptides
Influenza A (strain A/Duck/Hong Kong/2986.1/2000 H5N1 genotype C) Neuraminidase 233-241, CVNGSCFTV has been described in:
Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells., J Virol, 2001 (PMID: 11689620)
Heterologous T cell immunity in severe hepatitis C virus infection., J Exp Med, 2005 (PMID: 15753202)
HLA-peptide multimer selection of adenovirus-specific T cells for adoptive T-cell therapy., J Immunother, 2013 (PMID: 23994889)

Documentation

Documentation for Influenza A (strain A/Duck/Hong Kong/2986.1/2000 H5N1 genotype C) Neuraminidase 233-241, CVNGSCFTV

Properties

Properties of Influenza A (strain A/Duck/Hong Kong/2986.1/2000 H5N1 genotype C) Neuraminidase 233-241, CVNGSCFTV

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Hepatitis, Influenza
Layout: Freeze-dried in glass vial
Organism: Influenza A
Protein Name: Neuraminidase
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Influenza A (strain A/Duck/Hong Kong/2986.1/2000 H5N1 genotype C) Neuraminidase 233-241, CVNGSCFTV

Information Values
Sequence: H-CVNGSCFTV-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote